Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective study-Reference-Cited by-同舟云学术

Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective study

Published:2016-02-15 Issue:1 Volume:9 Page:
ISSN:2052-3211
Container-title:Journal of Pharmaceutical Policy and Practice
language:en
Short-container-title:J of Pharm Policy and Pract

Author:

Kalemeera Francis,Mengistu Assegid T.,Gaeseb Johannes

Publisher

Springer Science and Business Media LLC

Subject

Pharmacy,Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s40545-016-0054-x

Reference21 articles.

1. WHO 2010. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach 2010 Revision. http://www.who.int/hiv/pub/arv/adult2010/en/index.html . Accessed Nov 15 2014.

2. Floyd S, Marston M, Baisley K, Wringe A, Herbst K, Chihana M, et al. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level – a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health. 2012. doi: 10.1111/j.1365-3156.2012.03032.x .

3. MoHSS. Directorate of Special Programmes. Republic of Namibia. National Guidelines for Antiretroviral Therapy. 3rd ed. 2010.

4. Boehringer Ingelhemin Pharmaceuticals, Inc. Viramune Prescribing Information. 2012. http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Viramune/Viramune.pdf Accessed October 2014.

5. Bonjoch A, Paredes R, Domingo P, Cervantes M, Pedrol E, Ribera E, et al. Long-term safety and efficacy of nevirapine-based approaches in HIV type 1- infected patients. AIDS Res Hum Retrovir. 2006;22(4):321–9.